Regeneron Pharmaceuticals (REGN) Construction in Progress (2013 - 2017)
Regeneron Pharmaceuticals (REGN) posted quarterly Construction in Progress of $408.9 million for Q4 2017, up 28.2% year-over-year from $318.9 million in Q4 2016, and up 28.2% quarter-over-quarter from $318.9 million in Q4 2016.
Regeneron Pharmaceuticals (REGN) Construction in Progress (2013 - 2017) Analysis & Trends
Regeneron Pharmaceuticals' Construction in Progress history runs 5 years deep, the most recent figure standing at $408.9 million for Q4 2017.
- In Q4 2017, Construction in Progress rose 28.2% year-over-year to $408.9 million; the TTM figure through Dec 2017 stood at $408.9 million (up 28.2% YoY), while the FY2017 annual figure was $408.9 million, up 28.2% from the prior year.
- Construction in Progress for Q4 2017 stood at $408.9 million, up from $318.9 million in the prior quarter.
- The five-year high for Construction in Progress was $579.8 million in Q4 2015, with the low at $142.4 million in Q4 2013.
- The 5-year median for Construction in Progress is $408.9 million (2017), against an average of $384.4 million.
- The sharpest annual moves came in 2014 and 2016: Construction in Progress soared 231.69% in 2014, then tumbled 45.0% in 2016.
- Regeneron Pharmaceuticals' Construction in Progress stood at $142.4 million in 2013, then jumped by 231.69% to $472.2 million in 2014, then rose by 22.79% to $579.8 million in 2015, then sank by 45.0% to $318.9 million in 2016, then gained by 28.2% to $408.9 million in 2017.
- Business Quant data shows REGN's Construction in Progress at $408.9 million in Q4 2017, $318.9 million in Q4 2016, and $579.8 million in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 152.67 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 408.86 Mn |
| Dec 31, 2016 | 318.93 Mn |
| Dec 31, 2015 | 579.83 Mn |
| Dec 31, 2014 | 472.23 Mn |
| Dec 31, 2013 | 142.37 Mn |